131 related articles for article (PubMed ID: 17973225)
1. [Accordance to guidelines for community acquired pneumonia in Europe and in the world].
Giejło M; Szmidt M
Pneumonol Alergol Pol; 2007; 75(2):173-9. PubMed ID: 17973225
[TBL] [Abstract][Full Text] [Related]
2. Community acquired bacterial pneumonia.
Anevlavis S; Bouros D
Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
[TBL] [Abstract][Full Text] [Related]
4. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
5. Application of antimicrobial stewardship to optimise management of community acquired pneumonia.
Bosso JA; Drew RH
Int J Clin Pract; 2011 Jul; 65(7):775-83. PubMed ID: 21676120
[TBL] [Abstract][Full Text] [Related]
6. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
Ferrer M; Menendez R; Amaro R; Torres A
Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
[TBL] [Abstract][Full Text] [Related]
7. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
[TBL] [Abstract][Full Text] [Related]
8. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
[TBL] [Abstract][Full Text] [Related]
9. [The antibacterial therapy of community-acquired pneumonia].
Khveshchuk PF; Rakov AL; Sinopal'nikov AI; Rudakova AV
Voen Med Zh; 1999 Jan; 320(1):25-36. PubMed ID: 10200622
[No Abstract] [Full Text] [Related]
10. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
11. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
12. New guidelines for the management of adult community-acquired pneumonia.
Armitage K; Woodhead M
Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
[TBL] [Abstract][Full Text] [Related]
13. The halo effect of adherence to guidelines extends to patients with severe community-acquired pneumonia requiring admission to an intensive care unit.
Marrie TJ
Clin Infect Dis; 2005 Dec; 41(12):1717-9. PubMed ID: 16288393
[No Abstract] [Full Text] [Related]
14. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
Chiang WC; Teoh OH; Chong CY; Goh A; Tang JP; Chay OM
Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
[TBL] [Abstract][Full Text] [Related]
15. [The place of the new quinolones in the guidelines on the treatment of community-acquired pneumonia].
Dorca J
Arch Bronconeumol; 1999 May; 35 Suppl 3():77-80. PubMed ID: 10410230
[No Abstract] [Full Text] [Related]
16. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
17. Community acquired pneumonia.
Loeb M
Clin Evid; 2002 Jun; (7):1358-68. PubMed ID: 12230751
[No Abstract] [Full Text] [Related]
18. Diagnosis and management of community-acquired pneumonia in adults.
Watkins RR; Lemonovich TL
Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
[TBL] [Abstract][Full Text] [Related]
19. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
Bodí M; Rodríguez A; Solé-Violán J; Gilavert MC; Garnacho J; Blanquer J; Jimenez J; de la Torre MV; Sirvent JM; Almirall J; Doblas A; Badía JR; García F; Mendia A; Jordá R; Bobillo F; Vallés J; Broch MJ; Carrasco N; Herranz MA; Rello J;
Clin Infect Dis; 2005 Dec; 41(12):1709-16. PubMed ID: 16288392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
